• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Intuitive Surgical's Q1 Earnings: A Robotic Surge

cafead

Administrator
Staff member
  • cafead   Apr 21, 2024 at 11:02: PM
via
  • Intuitive Surgical outperformed analyst expectations for both EPS and revenue for Q1.
  • Regulatory approvals for da Vinci 5 and a single-port surgical system set the stage for expansion.
  • The company made progress in the number of procedures performed.

article source